Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dicrotophos |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Dicrotophos inhibits the expression of DME UGT2B4 |
[1] |
Health or Environmental Toxicant(s) |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cyanotoxin |
DME Modulation |
Cylindrospermopsin inhibits the expression of DME UGT2B4 |
[2] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME UGT2B4 |
[3], [4] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dust |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Dust up-regulates the expression of DME UGT2B4 |
[5] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Amentoflavone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01195
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT2B4 |
[6] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 9 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME UGT2B4 |
[7] |
Beclomethasone dipropionate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00278
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Beclomethasone dipropionate up-regulates the expression of DME UGT2B4 |
[8] |
Bosentan |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00148
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Bosentan inhibits the expression of DME UGT2B4 |
[9] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME UGT2B4 |
[10] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME UGT2B4 |
[11], [12] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME UGT2B4 |
[13] |
Estradiol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol inhibits the expression of DME UGT2B4 |
[3] |
Fenofibrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Fenofibrate up-regulates the expression of DME UGT2B4 |
[14] |
Urethane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane inhibits the expression of DME UGT2B4 |
[15] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Hymecromone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00555
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1/2 |
DME Modulation |
Hymecromone induces the drug-metabolizing activity of DME UGT2B4 |
[16] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME UGT2B4 |
[17] |
|
|
|
|
|
|